Dr. John M. Kunzeman, MD
Ophthalmology (Ophthalmology Physician)
At a glance
- In the NPI registry since
- 2023
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2023Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
MO license 2023019679 -
Internal Medicine Physician
MO license 2023019679 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Latanoprost Other prescribers in Kansas City, MO | 21 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Kansas City, MO | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 9 payments worth $588 in total to this clinician.
| Dompe US, Inc. | $224 |
|---|---|
| Bausch & Lomb Americas Inc. | $159 |
| AbbVie Inc. | $148 |
| Alcon Vision LLC | $28.55 |
| Ani Pharmaceuticals, Inc. | $28.46 |
| Food and Beverage | $588 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.